Rina Wolf

Rina Wolf is an accomplished professional with extensive experience in the molecular diagnostics and healthcare industries. Currently serving as Vice President of Strategic Commercialization, Consulting and Industry Affairs at Xifin, Inc. since October 2009, Rina Wolf specializes in providing consulting services to Molecular Diagnostic Laboratories, assisting with commercialization strategies and pricing optimization. Previous roles include Vice President of Reimbursement & Regulatory Affairs at Axial Biotech, Inc., Vice President of Reimbursement and Payor Relations at RedPath Integrated Pathology, Director of Reimbursement & Payor Relations at Genomic Health, and Vice President of Reimbursement & Contracts at Eoterix. Rina Wolf holds a Master’s degree in Health Administration from the University of La Verne and a Bachelor's degree from UCLA.